SHANGHAI--(BUSINESS WIRE)--ShangPharma Corporation (NYSE:SHP) (“ShangPharma” or the “Company”), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that Kevin Chen, Chief Operating Officer and Chief Financial Officer of ShangPharma, will be presenting at two investor conferences in Hong Kong on December 6 and 7, 2010:
